Influenza Diagnostics Market is estimated to be US$ 7.06 billion by 2022 with a CAGR of 13.4 % over the forecast period (2022-2032) With Top Most Key Players - Genes2Me, 3M Company, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffman-LA Roche AG, Be

Influenza is also called as 'Flu' which is contagious respiratory illness caused by influenza viruses. Symptoms of influenza are cough, runny nose, sore throat, fever, fatigue, headache and muscle ache. Not everyone with flu has a fever. People with 65 years and older, pregnant ladies are at higher risk of developing serious complications from influenza. Number of test are available in diagnosis of influenza virus. Viral culture, RT-PCR, immunofluorescence assay, serology, rapid molecular assays are diagnostic test available for influenza. Rapid molecular assays provide accurate results with high sensitivity and specificity within 20 minutes. Respiratory specimens are collected close to illness for maximizing detection of influenza virus. Viral culture diagnostic test is performed when there is outbreak of respiratory illness with suspected influenza. For determining influenza A & B virus strains causing illness, collection of respiratory samples for viral culture is required. Viral culture helps in identifying other causes of illness during outbreak of influenza like illness. Rapid Influenza Diagnostic Tests (RIDTS) are antigen detecting test which helps in detection of influenza virus within 15 minutes with high specificity and lower to moderate sensitivity. Immunofluorescence assays are antigen detection assays in which fluorescent microscope is used for producing results within 2 to 4 hours with moderate sensitivity & high specificity. Direct and indirect fluorescent antibody staining assays are used in detecting influenza A & B virus in respiratory tract specimens. Rapid immunofluorescence assay utilize an analyzer device for producing results within 15 minutes. RT-PCR has become the gold standard in diagnosis of influenza as it provides accurate result with high sensitivity and specificity. Rise in influenza virus and advancement in diagnosis has given positive impact on Influenza Diagnostic market growth.

To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Influenza-Diagnostics-Market-4977

The report "Influenza Diagnostics Market, By Type (RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and Others) By End-Users (Hospitals, Clinics, Diagnostic Laboratories and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"

Key Highlights:
• In October 2021, Hologic has launched multiplex 'Aptima SARS-CoV-2/Flu Assay' in Europe and North America. Newly launched assay kit can be used with anterior nasal swab & nasopharyngeal sample types. Newly launched assay kit has provided ability for detecting multiple infectious agents and differentiation of respiratory viruses simultaneously. It has received authorization by FDA in an emergency use.
• In September 2022, Siemens Healthineers has announced the launch of two combination test kit 'FTD SARS CoV-2/Flu A/Flu B/HRSV PCR' for detecting COVID-19 virus, Influenza virus and other seasonal respiratory pathogens. Newly launched test kit provides high sensitivity and specificity with result in 15 minutes. It will help in reducing spread of SARS-CoV-2 and seasonal respiratory viruses.

Analyst View:
Rise in prevalence of influenza virus has given rise in use of influenza test kits. Rapid growth in urban population has become the major factor in rising influenza virus due to overcrowd, slum areas, poor hygiene, air pollution which has led to cause of respiratory diseases. Change in rapid weather variability, global warming has given positive impact in rise of influenza virus. However, rise in prevalence of influenza virus, rapid growth in urban population and change in rapid weather variability is expected to boost the growth of Influenza Diagnostic Market. Some test kits perform poorly which result in misdiagnosed of influenza with serious consequences like failure in use of antiviral therapy and inappropriate use of antibiotics. There is need to solve the issues of test kits which perform poorly. Standard and high quality test kits with accurate results are highly recommended. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on"Influenza Diagnostics Market, By Type (RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and Others) By End-Users (Hospitals, Clinics, Diagnostic Laboratories and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"

Click To Get Sample Report:-
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4977

Segments Covered in the Report:

Influenza Diagnostics Market, By Type:
• RT-PCR
• Viral Culture
• Antigen Detection Tests
• Serological Assays
• Simple Amplification-based Assays
• Molecular Assays
• Others
Influenza Diagnostics Market, By End-Users:
• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

Key Market Insights from the report:
Influenza Diagnostics Market accounted for US$ 7.06 billion in 2022 and is estimated to be US$ 19.6 billion by 2032 and is anticipated to register a CAGR of 13.4%. The Influenza Diagnostics Market is segmented based on Type, End-Users and Region.
• Based on Type, Influenza Diagnostics Market is segmented into RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and others.
• Based on End-Users, Influenza Diagnostics Market is segmented into Hospitals, Clinics, Diagnostic Laboratories and others.
• By Region, the Influenza Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Influenza Diagnostics Market:
The prominent players operating in the Influenza Diagnostics Market includes, Genes2Me, 3M Company, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffman-LA Roche AG, Becton Dickinson and Company, Quidel Corporation, Virax BioLabs, Luminex Corporation, Hologic, and others. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Other Related Reports:-

https://www.prophecymarketinsights.com/market_insight/-Behavioral-Biometrics-Market-By-150

https://www.prophecymarketinsights.com/market_insight/-integrated-platform-as-a-service-ipaas-market-2900

https://www.prophecymarketinsights.com/market_insight/Global-Internet-of-Things-IOT-250

964 E. BadilloStreet #2042 Covina, CA 91724
US toll free: +1 860 531 2701
Rest of world: + 91 7775049802
Email:sales@prophecymarketinsights.com
Website:www.prophecymarketinsights.com

About us:Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.